Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of ZG-001 capsules in adults with depression and suicidal ideation or behavior
CTR20250124Phase 2Active
- Sponsor
- Zhigen Pharmaceutical
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ZG-001 in major depressive disorder (MDD), sponsored by Zhigen Pharmaceutical. Started Mar 2025; status: active.
02
Drugs
ZG-001
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on CTR20250124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250124.